1. Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. Issue 1 (December 2017) Authors: Mariot, Virginie; Joubert, Romain; Hourdé, Christophe; Féasson, Léonard; Hanna, Michael; Muntoni, Francesco; Maisonobe, Thierry; Servais, Laurent; Bogni, Caroline; Panse, Rozen; Benvensite, Olivier; Stojkovic, Tanya; Machado, Pedro; Voit, Thomas; Buj-Bello, Ana; Dumonceaux, Julie Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO195 Outcome measures for duchenne muscular dystrophy: implications for trials. (1st December 2017) Authors: Domingos, Joana; Eagle, Michelle; Moraux, Amelie; Butler, Jordan; Decostre, Valerie; Ridout, Deborah; Mayhew, Anna; Selby, Victoria; Guglieri, Michela; Holst, Menno Van der; Jansen, Merel; Verschuuren, Jan GM; Groot, Imelda de; Niks, Erik; Servais, Laurent; Hogrel, Jean-Yves; Straub, Volker; Voit... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88(2017)Supplement 1 Page Start: A63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rescue of cardiomyopathy through U7snRNA‐mediated exon skipping in Mybpc3‐targeted knock‐in mice. Issue 7 (29th May 2013) Authors: Gedicke‐Hornung, Christina; Behrens‐Gawlik, Verena; Reischmann, Silke; Geertz, Birgit; Stimpel, Doreen; Weinberger, Florian; Schlossarek, Saskia; Précigout, Guillaume; Braren, Ingke; Eschenhagen, Thomas; Mearini, Giulia; Lorain, Stéphanie; Voit, Thomas; Dreyfus, Patrick A.; Garcia, Luis; Carrier,... Journal: EMBO molecular medicine Issue: Volume 5:Issue 7(2013:Jul.) Page Start: 1128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy. Issue 6 (22nd October 2021) Authors: Mariot, Virginie; Joubert, Romain; Le Gall, Laura; Sidlauskaite, Eva; Hourde, Christophe; Duddy, William; Voit, Thomas; Bencze, Maximilien; Dumonceaux, Julie Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 12:Issue 6(2021) Page Start: 2079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients. (22nd March 2018) Authors: Catapano, Francesco; Domingos, Joana; Perry, Mark; Ricotti, Valeria; Phillips, Lauren; Servais, Laurent; Seferian, Andreea; Groot, Imelda de; Krom, Yvonne D; Niks, Erik H; Verschuuren, Jan JGM; Straub, Volker; Voit, Thomas; Morgan, Jennifer; Muntoni, Francesco Journal: Epigenomics Issue: Volume 10:Number 7(2018) Page Start: 875 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Issue 1 (December 2015) Authors: Pinto-Mariz, Fernanda; Rodrigues Carvalho, Luciana; Prufer De Queiroz Campos Araujo, Alexandra; De Mello, Wallace; Gonçalves Ribeiro, Márcia; Cunha, Maria; Cabello, Pedro; Riederer, Ingo; Negroni, Elisa; Desguerre, Isabelle; Veras, Mariana; Yada, Erica; Allenbach, Yves; Benveniste, Olivier; Voit,... Journal: Skeletal muscle Issue: Volume 5:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines. Issue 1 (December 2016) Authors: Thorley, Matthew; Duguez, Stéphanie; Mazza, Emilia Maria Cristina; Valsoni, Sara; Bigot, Anne; Mamchaoui, Kamel; Harmon, Brennan; Voit, Thomas; Mouly, Vincent; Duddy, William Journal: Skeletal muscle Issue: Volume 6:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy. Issue 4 (29th August 2016) Authors: Buyse, Gunnar M.; Voit, Thomas; Schara, Ulrike; Straathof, Chiara S.M.; D'Angelo, Maria Grazia; Bernert, Günther; Cuisset, Jean‐Marie; Finkel, Richard S.; Goemans, Nathalie; Rummey, Christian; Leinonen, Mika; Mayer, Oscar H.; Spagnolo, Paolo; Meier, Thomas; McDonald, Craig M. Journal: Pediatric pulmonology Issue: Volume 52:Issue 4(2017) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy. Issue 3 (26th May 2021) Authors: Amor, Fatima; Vu Hong, Ai; Corre, Guillaume; Sanson, Mathilde; Suel, Laurence; Blaie, Stephanie; Servais, Laurent; Voit, Thomas; Richard, Isabelle; Israeli, David Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 12:Issue 3(2021) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial. Issue 9979 (2nd May 2015) Authors: Buyse, Gunnar M; Voit, Thomas; Schara, Ulrike; Straathof, Chiara S M; D'Angelo, M Grazia; Bernert, Günther; Cuisset, Jean-Marie; Finkel, Richard S; Goemans, Nathalie; McDonald, Craig M; Rummey, Christian; Meier, Thomas Journal: Lancet Issue: Volume 385:Issue 9979(2015) Page Start: 1748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗